IBIO, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
IBIO, INC. (IBIO) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$1.59 million for the 12-month period ending 2017-06-30, per its 10-K filed 2017-09-15.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-09-15
- IBIO, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$525.00K.
- IBIO, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was -$303.00K.
- IBIO, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was -$163.00K, a 1353.85% decline year-over-year.
- IBIO, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was -$602.00K.
- IBIO, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was -$1.59M.
- IBIO, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$68.00K.
- IBIO, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$215.00K.
- IBIO, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$259.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|---|
| 2017-06-30 | -$525.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-15 | -$828.00K derived: sum of 2 quarters · filed 2017-09-15 | -$991.00K derived: sum of 3 quarters · filed 2017-09-15 | -$1.59M 10-K · filed 2017-09-15 | |
| 2017-03-31 | -$303.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-15 | -$466.00K derived: sum of 2 quarters · filed 2017-05-15 | -$1.07M 10-Q · filed 2017-05-15 | -$1.13M derived: sum of 4 quarters · filed 2017-09-15 | |
| 2016-12-31 | -$163.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-21 | -$765.00K 10-Q · filed 2017-02-21 | -$825.00K derived: sum of 3 quarters · filed 2017-09-15 | -$828.00K derived: sum of 4 quarters · filed 2017-09-15 | |
| 2016-09-30 | -$602.00K 10-Q · filed 2016-11-18 | -$662.00K derived: sum of 2 quarters · filed 2017-09-15 | -$665.00K derived: sum of 3 quarters · filed 2017-09-15 | -$652.00K derived: sum of 4 quarters · filed 2017-09-15 | |
| 2016-06-30 | -$60.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-15 | -$63.00K derived: sum of 2 quarters · filed 2017-09-15 | -$50.00K derived: sum of 3 quarters · filed 2017-09-15 | -$68.00K 10-K · filed 2017-09-15 | |
| 2016-03-31 | -$3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-15 | $10.00K derived: sum of 2 quarters · filed 2017-05-15 | -$8.00K 10-Q · filed 2017-05-15 | -$71.00K derived: sum of 4 quarters · filed 2017-05-15 | |
| 2015-12-31 | $13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-21 | -$5.00K 10-Q · filed 2017-02-21 | -$68.00K derived: sum of 3 quarters · filed 2017-02-21 | -$120.00K derived: sum of 4 quarters · filed 2017-02-21 | |
| 2015-09-30 | -$18.00K 10-Q · filed 2016-11-18 | -$81.00K derived: sum of 2 quarters · filed 2016-11-18 | -$133.00K derived: sum of 3 quarters · filed 2016-11-18 | -$202.00K derived: sum of 4 quarters · filed 2016-11-18 | |
| 2015-06-30 | -$63.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-10-13 | -$115.00K derived: sum of 2 quarters · filed 2016-10-13 | -$184.00K derived: sum of 3 quarters · filed 2016-10-13 | -$215.00K 10-K · filed 2016-10-13 | |
| 2015-03-31 | -$52.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-23 | -$121.00K derived: sum of 2 quarters · filed 2016-05-23 | -$152.00K 10-Q · filed 2016-05-23 | -$211.00K derived: sum of 4 quarters · filed 2016-05-23 | |
| 2014-12-31 | -$69.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-22 | -$100.00K 10-Q · filed 2016-02-22 | -$159.00K derived: sum of 3 quarters · filed 2016-02-22 | -$277.00K derived: sum of 4 quarters · filed 2016-02-22 | |
| 2014-09-30 | -$31.00K 10-Q · filed 2015-11-13 | -$90.00K derived: sum of 2 quarters · filed 2015-11-13 | -$208.00K derived: sum of 3 quarters · filed 2015-11-13 | -$231.00K derived: sum of 4 quarters · filed 2015-11-13 | |
| 2014-06-30 | -$59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-10-13 | -$177.00K derived: sum of 2 quarters · filed 2015-10-13 | -$200.00K derived: sum of 3 quarters · filed 2015-10-13 | -$259.00K 10-K · filed 2015-10-13 | |
| 2014-03-31 | -$118.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-15 | -$141.00K derived: sum of 2 quarters · filed 2015-05-15 | -$200.00K 10-Q · filed 2015-05-15 | -$237.00K derived: sum of 4 quarters · filed 2015-05-15 | |
| 2013-12-31 | -$23.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-24 | -$82.00K 10-Q · filed 2015-02-24 | -$119.00K derived: sum of 3 quarters · filed 2015-02-24 | -$166.00K derived: sum of 4 quarters · filed 2015-02-24 | |
| 2013-09-30 | -$59.00K 10-Q · filed 2014-11-14 | -$96.00K derived: sum of 2 quarters · filed 2014-11-14 | -$143.00K derived: sum of 3 quarters · filed 2014-11-14 | ||
| 2013-06-30 | -$37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-29 | -$84.00K derived: sum of 2 quarters · filed 2014-09-29 | -$195.00K 10-K · filed 2014-09-29 | ||
| 2013-03-31 | -$47.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-15 | -$158.00K 10-Q · filed 2014-05-15 | |||
| 2012-12-31 | -$111.00K 10-Q · filed 2014-02-14 | -$2.69M 10-Q · filed 2013-02-19 | |||
| 2011-12-31 | -$2.01M 10-Q · filed 2013-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |